Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
HLS.TOthis companyHLS Therapeutics Inc.	CA$4.50	-8.77×	1.8×	1.96×	8.25×	26.6%	42.5%	-7.4%	-22.4%	-20.5%	-3.5%	14.3%	0.81×	2.11×	-0.58×	1.11×	0.0%	5	-1.12	2	C+
BHCBausch Health Companies Inc.	$8.29	16.16×	-4.66×	0.25×	7.07×	2047.1%	70.7%	21.3%	1.5%	-28.4%	3.2%	38.9%	-38.35×	6.26×	1.36×	1.47×	0.0%	6	0.22	2	C+
Peer median	—	16.16×	-4.66×	0.25×	7.07×	2047.1%	70.7%	21.3%	1.5%	-28.4%	3.2%	38.9%	-38.35×	6.26×	1.36×	1.47×	0.0%	6	0.22	2	—